
Sudhir Kumar Singh
About Sudhir Kumar Singh
Data last updated:
Sudhir Kumar Singh was a Ceo at Cohance Lifesciences Limited (2023–2025), Director at Intox Private Limited (2021–2023) and Whole-Time Director at Jubilant Chemsys Limited (2009–2013), and held 1 more directorship. The companies operate in Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ceo | 29 Sep 2023 | ||||
| Director | 13 Dec 2021 | 2000 | ₹45.44 Cr (FY 2025) | Active | |
| Whole-Time Director | 10 Mar 2009 | 2004 | ₹126 Cr (FY 2019) | Amalgamated | |
| Whole-Time Director | 01 Dec 2023 | 2016 | ₹30.43 Cr (FY 2024) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudhir Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudhir Kumar Singh
Sudhir Kumar Singh was first appointed on 10 Mar 2009 as Whole-Time Director at Jubilant Chemsys Limited. The most recent appointment on record is 01 Dec 2023 at Casper Pharma Private Limited.
Sudhir Kumar Singh held 4 earlier board appointments: Cohance Lifesciences Limited (Ceo, 29 Sep 2023 to 31 Jul 2025); Intox Private Limited (Director, 13 Dec 2021 to 18 Apr 2023); Jubilant Chemsys Limited (Whole-Time Director, 10 Mar 2009 to 31 Jan 2013); Casper Pharma Private Limited (Whole-Time Director, from 01 Dec 2023).